New Version of CRISPR, Developed by Feng Zhang–Led Team, Can Target and Edit RNA

A research team led by Feng Zhang, Ph.D., has developed a new version of the gene-editing tool CRISPR (clustered regularly interspaced short palindromic repeats) that offers several advantages over its familiar DNA-editing counterpart through its ability to target and edit RNA.Dr. Zhang, of the Broad Institute of MIT and Harvard, and an original innovator of CRISPR/Cas9 technology, and colleagues, said this new CRISPR—which uses a version of the Cas13 enzyme—would enable transient ed